1. Home
  2. JSPR vs GHI Comparison

JSPR vs GHI Comparison

Compare JSPR & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$1.83

Market Cap

48.1M

Sector

Health Care

ML Signal

HOLD

Logo Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

GHI

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

HOLD

Current Price

$7.03

Market Cap

161.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
JSPR
GHI
Founded
2018
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
161.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JSPR
GHI
Price
$1.83
$7.03
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$21.44
$13.00
AVG Volume (30 Days)
4.0M
172.3K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
20.61%
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
N/A
$26,247,399.00
Revenue This Year
N/A
$201.02
Revenue Next Year
N/A
$2.87
P/E Ratio
N/A
$42.56
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$6.01
52 Week High
$22.99
$13.29

Technical Indicators

Market Signals
Indicator
JSPR
GHI
Relative Strength Index (RSI) 50.28 50.77
Support Level $1.61 $6.75
Resistance Level $1.96 $7.50
Average True Range (ATR) 0.13 0.31
MACD 0.03 0.13
Stochastic Oscillator 63.89 61.01

Price Performance

Historical Comparison
JSPR
GHI

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: